579 related articles for article (PubMed ID: 25920083)
1. Liver cancer: Approaching a personalized care.
Bruix J; Han KH; Gores G; Llovet JM; Mazzaferro V
J Hepatol; 2015 Apr; 62(1 Suppl):S144-56. PubMed ID: 25920083
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
Laohawetwanit T; Lerttanatum N; Wanpiyarat N; Manasilp N; Chaiparnich S
Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and cholangiocarcinoma: an update.
Yazici C; Niemeyer DJ; Iannitti DA; Russo MW
Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):63-82. PubMed ID: 24245910
[TBL] [Abstract][Full Text] [Related]
4. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Sapisochin G; Ivanics T; Heimbach J
Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
[TBL] [Abstract][Full Text] [Related]
5. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study.
Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP
J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of liver cancer and personalized therapy.
Li L; Wang H
Cancer Lett; 2016 Sep; 379(2):191-7. PubMed ID: 26213370
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for hepatic and biliary malignancy.
Wall WJ
Semin Liver Dis; 2000; 20(4):425-36. PubMed ID: 11200413
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
9. [Regional therapy of liver tumors].
Spangenberg HC; Mohr L; Blum HE
Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
[TBL] [Abstract][Full Text] [Related]
11. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Wacker F; Dewald C
Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
[TBL] [Abstract][Full Text] [Related]
12. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
Rana A; Hong JC
Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
[TBL] [Abstract][Full Text] [Related]
13. Current role of portal vein embolization/hepatic artery chemoembolization.
Kokudo N; Makuuchi M
Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666
[TBL] [Abstract][Full Text] [Related]
14. [Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Helmberger T; Pereira PL
Radiologe; 2022 Mar; 62(3):234-238. PubMed ID: 35171313
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
Gennari L
Ann Ital Chir; 2008; 79(2):79-80. PubMed ID: 18727268
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference.
Dufour JF; Johnson P
J Hepatol; 2010 Feb; 52(2):296-304. PubMed ID: 20006399
[No Abstract] [Full Text] [Related]
17. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.
Unzueta A; Cabrera R
Clin Liver Dis; 2017 May; 21(2):231-251. PubMed ID: 28364811
[TBL] [Abstract][Full Text] [Related]
18. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
19. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Survival of Combined Hepatocellular-Cholangiocarcinoma: A Nationwide Study.
Chen PD; Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Oct; 26(10):e1774-e1785. PubMed ID: 34213048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
